Aberrant activation of cell cycle molecules has been postulated to play a role in apoptosis (“catastrophic cell cycle”). Here we show that in noncycling developing thymocytes, the cyclin- dependent kinase Cdk2 is activated in response to all specific and nonspecific apoptotic stimuli tested, including peptide-specific thymocyte apoptosis. Cdk2 was found to function upstream of the tumor suppressor p53, transactivation of the death promoter Bax, alterations of mitochondrial permeability, Bcl-2, caspase activation, and caspase-dependent proteolytic cleavage of the retinoblastoma protein. Inhibition of Cdk2 completely protected thymocytes from apoptosis, mitochondrial changes, and caspase activation. These data provide the first evidence that Cdk2 activity is crucial for the induction of thymocyte apoptosis.
Skip Nav Destination
Article navigation
15 March 1999
Article|
March 15 1999
The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis
Anne Hakem,
Anne Hakem
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Search for other works by this author on:
Takehiko Sasaki,
Takehiko Sasaki
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Search for other works by this author on:
Ivona Kozieradzki,
Ivona Kozieradzki
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Search for other works by this author on:
Josef M. Penninger
Josef M. Penninger
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Search for other works by this author on:
Anne Hakem
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Takehiko Sasaki
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Ivona Kozieradzki
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Josef M. Penninger
From The Amgen Institute, the Ontario Cancer Institute, and the Department of Medical Biophysics and the Department of Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1
Address correspondence to Josef M. Penninger, The Amgen Institute, 620 University Ave., Suite 706, Toronto, Ontario, Canada M5G 2C1. Phone: 416-204-2241; Fax: 416-204-2278; E-mail: [email protected]
A. Hakem and J.M. Penninger are supported by a grant from the Medical Research Council of Canada.
Received:
November 12 1998
Revision Received:
December 23 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (6): 957–968.
Article history
Received:
November 12 1998
Revision Received:
December 23 1998
Citation
Anne Hakem, Takehiko Sasaki, Ivona Kozieradzki, Josef M. Penninger; The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis . J Exp Med 15 March 1999; 189 (6): 957–968. doi: https://doi.org/10.1084/jem.189.6.957
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement